MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

TRACON Pharmaceuticals Company Profile (NASDAQ:TCON)

Consensus Ratings for TRACON Pharmaceuticals (NASDAQ:TCON) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $22.00 (238.98% upside)

Analysts' Ratings History for TRACON Pharmaceuticals (NASDAQ:TCON)
Show:
DateFirmActionRatingPrice TargetActions
2/1/2016OppenheimerReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/8/2015Roth CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/2/2015Stifel NicolausBoost Price TargetBuy$16.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/24/2015Needham & Company LLCInitiated CoverageBuy$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/29/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha